title: Corrigendum: Repurposing the Chemical Scaffold of the Anti-Arthritic Drug Lobenzarit to Target Tryptophan Biosynthesis in Mycobacterium tuberculosis.
authors.forename: Genevieve L
authors.initials: GL
authors.lastname: Evans
authors.forename: Swarna A
authors.initials: SA
authors.lastname: Gamage
authors.forename: Esther M M
authors.initials: EM
authors.lastname: Bulloch
authors.forename: Edward N
authors.initials: EN
authors.lastname: Baker
authors.forename: William A
authors.initials: WA
authors.lastname: Denny
authors.forename: J Shaun
authors.initials: JS
authors.lastname: Lott
keywords: X-ray crystallography; drug design; enzyme inhibitors; hydrogen bonds; tryptophan biosynthesis